BUND FINANCE

BUND FINANCE › Stocks › ISRG

Intuitive Surgical, Inc. (ISRG)

NASDAQ · Stock price, chart and technical analysis

US$420.95-9.58 (-2.23%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$430.53
OpenUS$430.20
Day rangeUS$420.84 – US$437.17
52-week rangeUS$328.57 – US$603.88
Market capUS$145.92B
Volume2.20M
50-day averageUS$420.62
200-day averageUS$428.72
Beta1.44

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$5.7BUS$6.2BUS$7.1BUS$8.4BUS$10.1B
Net incomeUS$1.7BUS$1.3BUS$1.8BUS$2.3BUS$2.9B
EPS (diluted)4.663.655.036.427.87
Gross margin69.3%67.4%66.4%67.5%66.0%
Operating margin31.9%25.4%24.8%28.1%29.3%
Net margin29.9%21.3%25.2%27.8%28.4%
Free cash flowUS$1.7BUS$958.4MUS$749.6MUS$1.3BUS$2.5B
Total debtUS$87.0MUS$0US$0US$0US$0
CashUS$1.3BUS$1.6BUS$2.8BUS$2.0BUS$3.4B

Compound annual growth: revenue 15.2% · net income 13.8% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E50.5x72.6x27.1x
EV / EBITDA33.9x52.2x16.5x
Operating margin28.4%—3.6%
Net margin25.5%—-0.0%
Debt / equity0.20—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Intuitive Surgical, Inc.

SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
CEODavid J. Rosa
Employees17,021
IPO date2000-06-16

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive…

www.intuitive.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice